A detailed history of Marathon Trading Investment Management LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Marathon Trading Investment Management LLC holds 10,800 shares of FULC stock, worth $34,992. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,800
Previous 45,000 76.0%
Holding current value
$34,992
Previous $424,000 84.43%
% of portfolio
0.02%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$5.98 - $9.31 $204,516 - $318,402
-34,200 Reduced 76.0%
10,800 $66,000
Q1 2024

May 10, 2024

BUY
$6.7 - $12.0 $301,500 - $540,000
45,000 New
45,000 $424,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $169M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.